gross profit bridgeinconsistent2022-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$5.65B
Fiscal year ended 2025-12-31Operating income
$337.91M
Fiscal year ended 2025-12-31Free cash flow
$217.14M
Fiscal year ended 2025-12-31Option Care Health, Inc. (OPCH) reported revenue of $5.65B and net income of $207.58M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Option Care Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.65B | $5.00B | $4.30B | $3.94B | $3.44B | $3.03B | $2.31B | $1.94B | $1.83B | $935.59M |
| Cost of revenue | $4.56B | $3.99B | $3.32B | Unavailable | $2.66B | $2.35B | $1.80B | $1.52B | $1.38B | $673.51M |
| Gross profit | $1.09B | $1.01B | $981.22M | Unavailable | $779.61M | $682.26M | $513.00M | $422.22M | $446.00M | $262.08M |
| Operating income | $337.91M | $321.83M | $314.60M | $240.23M | $190.84M | $110.76M | -$319.00K | $38.27M | $27.28M | -$10.99M |
| Net income | $207.58M | $211.82M | $267.09M | $150.56M | $139.90M | -$8.08M | -$75.92M | -$6.12M | $3.88M | -$42.76M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 163.36M | shares 172.84M | shares 180.38M | shares 182.08M | shares 181.20M | shares 180.97M | shares 156.28M | Unavailable | Unavailable | Unavailable |
| Pretax income | $282.90M | $283.60M | $358.74M | $205.77M | $116.49M | -$5.24M | -$78.19M | -$51.02M | -$67.43M | -$34.16M |
| Income tax expense | $75.32M | $71.78M | $91.65M | $55.21M | -$23.40M | $2.83M | -$2.27M | -$2.65M | -$18.58M | $2.02M |
| Diluted EPS | $1.27 | $1.23 | $1.48 | $0.83 | $0.77 | $-0.04 | $-0.49 | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | $682.45M | $630.25M | $607.43M | $566.12M | $525.71M | $500.20M | $459.63M | $345.88M | $338.46M | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $47.26M | $39.62M | $38.80M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $232.62M | $412.56M | $343.85M | $294.19M | $119.42M | $99.26M | $67.06M | $36.39M | $39.46M | $9.57M |
| Total assets | $3.46B | $3.42B | $3.22B | $3.11B | $2.79B | $2.65B | $2.59B | $1.43B | $603.09M | $604.98M |
| Current assets | $1.26B | $1.32B | $1.09B | $994.34M | $710.26M | $657.01M | $558.65M | $467.42M | $186.59M | $173.33M |
| Total liabilities | $2.13B | $2.02B | $1.80B | $1.73B | $1.62B | $1.63B | $1.68B | $825.39M | $605.76M | $566.60M |
| Current liabilities | $829.35M | $780.15M | $618.31M | $565.35M | $459.70M | $434.02M | $330.00M | $240.00M | $105.13M | $130.15M |
| Total equity incl. NCI | $1.33B | $1.40B | $1.42B | $1.39B | $1.18B | $1.02B | $906.83M | $602.82M | $606.10M | $600.77M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $471.15M | $388.13M | $274.00M | $224.28M | $183.10M | $158.60M | $115.88M | $83.34M | $38.04M | $36.16M |
| Accounts receivable | $473.57M | $409.73M | $377.66M | $377.54M | $338.24M | $328.34M | $324.42M | $310.17M | $85.52M | $109.09M |
| Goodwill | $1.61B | $1.54B | $1.54B | $1.53B | $1.48B | $1.43B | $1.43B | $632.47M | $627.39M | $365.95M |
| Long-term debt | $1.15B | $1.10B | $1.06B | $1.06B | $1.06B | $1.12B | $1.28B | $535.22M | $478.87M | $433.41M |
| Accounts payable | $639.83M | $610.78M | $426.51M | $378.76M | $279.25M | $282.91M | $221.06M | $187.89M | $65.96M | $64.42M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $258.45M | $323.39M | $371.30M | $267.55M | $208.57M | $127.39M | $39.47M | $24.43M | $37.87M | -$42.54M |
| Capital expenditures | $41.31M | $35.61M | $41.87M | $35.36M | $25.63M | $26.88M | $28.29M | $26.28M | $24.96M | Unavailable |
| Investing cash flow | -$161.08M | -$36.47M | -$56.51M | -$108.05M | -$111.54M | -$26.33M | -$727.83M | -$37.00M | -$24.47M | -$73.21M |
| Financing cash flow | -$277.30M | -$218.21M | -$265.13M | $15.27M | -$76.87M | -$68.85M | $719.02M | -$4.15M | -$5.15M | $109.74M |
| Net change in cash | -$179.94M | $68.72M | $49.66M | $174.76M | $20.16M | $32.21M | $30.66M | -$16.72M | $8.25M | -$6.01M |
| Stock-based compensation | $39.96M | $36.14M | $30.48M | $16.78M | $9.58M | $2.92M | $4.17M | $2.14M | $1.46M | $1.80M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $309.95M | $252.73M | $250.26M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $67.54M | $60.91M | $59.20M | $60.56M | $63.06M | $71.31M | $53.69M | $38.06M | $34.66M | $22.02M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $217.14M | $287.79M | $329.43M | $232.19M | $182.94M | $100.52M | $11.18M | -$1.85M | $12.92M | Unavailable |
| Gross margin | 19.3% | 20.3% | 22.8% | 22.0% | 22.7% | 22.5% | 22.2% | 21.8% | 24.4% | 28.0% |
| Operating margin | 6.0% | 6.4% | 7.3% | 6.1% | 5.5% | 3.7% | -0.0% | 2.0% | 1.5% | -1.2% |
| FCF margin | 3.8% | 5.8% | 7.7% | 5.9% | 5.3% | 3.3% | 0.5% | -0.1% | 0.7% | Unavailable |
| SBC / revenue | 0.7% | 0.7% | 0.7% | 0.4% | 0.3% | 0.1% | 0.2% | 0.1% | 0.1% | 0.2% |
| Current ratio | 1.53x | 1.70x | 1.77x | 1.76x | 1.55x | 1.51x | 1.69x | 1.95x | 1.77x | 1.33x |
| Revenue YoY growth | 13.0% | 16.2% | 9.1% | 14.7% | 13.4% | 31.3% | 19.1% | 6.1% | 95.4% | Unavailable |
| Net margin | 3.7% | 4.2% | 6.2% | 3.8% | 4.1% | -0.3% | -3.3% | -0.3% | 0.2% | -4.6% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.7% | 0.7% | 1.0% | 0.9% | 0.7% | 0.9% | 1.2% | 1.4% | 1.4% | Unavailable |
| Long-term debt / equity | 0.87x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 26.6% | 25.3% | 25.5% | 26.8% | -20.1% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OPCH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-29View SEC filing
10-K · Filed 2025-02-26View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2017-12-31
Difference 608778000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2016-12-31
Difference 562389000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.